Skip to main content

Industry involvement

Engineering Innovation in Health (EIH) develops technical solutions to pressing challenges in health. We welcome projects from your company that will benefit from a collaborative working team of industry professionals, UW students, and faculty.

Benefits

By participating in EIH, you have the opportunity to:

  • Develop innovative technical solutions that bring value to your company.
  • Vet a solution to a challenging problem, perhaps one that you don’t have the resources to pursue in-house.
  • Generate a deeper understanding of a health challenge, market, current solutions, intellectual property, and regulatory strategy that engages a comprehensive set of stakeholders.
  • Work closely with a diverse group of UW students and faculty from engineering, health sciences, and business.
  • Strengthen your relationship with the UW for recruiting student talent and for engaging in future projects.
  • Leverage world class infrastructure and facilities at UW.
  • Receive a nonexclusive commercial license to any project intellectual property developed by the student team or UW employees.

Involvement

The Engineering Innovation in Health program runs for 9 months. Projects typically start in the fall (October) and run for three quarters (ending in June).

Participating companies pay a sponsorship fee and designate an employee lead to mentor the team. The mentor meets with the team weekly to help them understand the problem in depth and guide the solution pathway.

Intellectual property is governed by existing federal and state laws and is subject to best practices of the University of Washington technology transfer office, CoMotion. A company wholly owns its existing intellectual property. A nonexclusive, commercial license will be granted to any project intellectual property developed by the student team or UW employees. Additional, pre-negotiated options for exclusive licenses have been standardized as part of the Washington Innovation Advantage Program.

The EIH process starts with industry sponsors or clinicians submitting a project idea that focuses on an unmet health challenge and ultimately ends with a working prototype solution, which can take the form of a device, process, or application. Project submissions are due on a rolling basis between May and August each year. We welcome you to reach out to us and discuss your ideas. Please contact EIHealth@uw.edu to learn more.

 

Submit a health challenge

 

Sample projects

For a full list of previous projects, visit the Projects section.

Lung Biopsy Needle  »

Lung biopsies are performed to diagnose lung cancer; however, biopsy needles can cause pneumothorax (collapsed lungs) due to positive pressure in the space between the lung and the chest wall. This needle includes a vacuum port to suck out the air leaked into this space and prevent pneumothorax. The vacuum remains in place after the biopsy to ensure the lung stays expanded during healing.

Image
Lung biopsy needle rendering

DopCuff: Blood Pressure Monitor for LVAD Patients »

Patients with terminal heart disease may be implanted with a left ventricular assist device (LVAD), which allows hospital discharge with an acceptable quality of life while awaiting a donor heart to become available or for destination therapy. Prevailing technology for LVAD uses continuous flow centrifugal pumps to provide circulatory support. Careful monitoring of blood pressure in LVAD patients is essential to reduce complications associated with LVADs. However, the non-pulsatile blood flow dynamics of these LVADs confounds accurate blood pressure measurement and cannot be performed using commercially available non-invasive blood pressure sphygmomanometers alone. DopCuff integrates doppler and automated cuff technology into a single blood pressure measuring device that is user-friendly and accurate for outpatient use in LVAD patients to satisfy a significant unmet clinical need for this growing population of patients and their caretakers. 

Image

EpiForAll (now called MedsForAll) »

Anaphylaxis is an acute, severe, and potentially life-threatening allergic reaction. A single shot of epinephrine can dramatically improve outcomes for anaphylaxis; however, epinephrine auto injectors can cost hundreds of dollars are not readily available in low- and middle-income countries. EpiForAll is an affordable epinephrine auto-injector used to treat anaphylaxis. EpiForAll revolutionizes auto-injectors by using readily available, low cost epinephrine ampules. EpiForAll won the 2017 Hollomon Health Innovation Challenge and continues to be developed at UW.

Image
Epi4All team